MED12 and leiomyoma: Overall, our results are compatible with the previous notion that mechanisms other than MED12 mutations, such as high mobility group AT-hook 2 (HMGA2) aberrations, drive the majority of histopathological variants while the great majority of common leiomyomas are MED12-mutation positive23, 29–32.